| scholarly article | Q13442814 |
| P50 | author | Jan-Mendelt Tillema | Q41674912 |
| Eoin P. Flanagan | Q44543777 | ||
| Andrew McKeon | Q80080033 | ||
| Elie Naddaf | Q85604737 | ||
| Brian G Weinshenker | Q88536678 | ||
| P2093 | author name string | Sean J Pittock | |
| Claudia F Lucchinetti | |||
| Marc C Patterson | |||
| Kenneth L Tyler | |||
| B Mark Keegan | |||
| James P Fryer | |||
| Padraig P Morris | |||
| Avi Gadoth | |||
| Karl N Krecke | |||
| John C Chen | |||
| Kevin Messacar | |||
| Divyanshu Dubey | |||
| Jiraporn Jitprapaikulsan | |||
| Eslam Shosha | |||
| Nicholas L Zalewski | |||
| A Sebastian Lopez-Chiriboga | |||
| Elia Sechi | |||
| P2860 | cites work | IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel | Q24646531 |
| International consensus diagnostic criteria for neuromyelitis optica spectrum disorders | Q26824579 | ||
| Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype | Q28273526 | ||
| The spectrum of MOG autoantibody-associated demyelinating diseases | Q28293355 | ||
| Unique transcriptome patterns of the white and grey matter corroborate structural and functional heterogeneity in the human frontal lobe | Q28534652 | ||
| MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome | Q30371412 | ||
| Consensus definitions proposed for pediatric multiple sclerosis and related disorders | Q34619721 | ||
| Spinal cord infarction: clinical and magnetic resonance imaging findings and short term outcome | Q35476997 | ||
| Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders | Q36002919 | ||
| The gray aspects of white matter disease in multiple sclerosis | Q37208525 | ||
| Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. | Q37227096 | ||
| A clinical approach to diagnosis of autoimmune encephalitis. | Q37343730 | ||
| Acute flaccid myelitis: A clinical review of US cases 2012-2015. | Q37397515 | ||
| Acute flaccid paralysis due to West nile virus infection in adults: A paradigm shift entity | Q37712155 | ||
| Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude | Q38083645 | ||
| MOG antibody-related disorders: common features and uncommon presentations. | Q38645211 | ||
| Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases. | Q38661715 | ||
| Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. | Q40165089 | ||
| Outcomes of Colorado children with acute flaccid myelitis at 1 year | Q40172214 | ||
| Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum | Q40902234 | ||
| A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA. | Q41511681 | ||
| Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients | Q46249225 | ||
| Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. | Q47284937 | ||
| Clinical presentation and prognosis in MOG-antibody disease: a UK study | Q47970245 | ||
| Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome | Q47998520 | ||
| Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis | Q48235947 | ||
| Clinical course of MOG antibody-associated recurrent demyelinating diseases | Q48237496 | ||
| Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses | Q49790336 | ||
| Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders. | Q51288270 | ||
| Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice. | Q52564312 | ||
| MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. | Q52803391 | ||
| Discriminating long myelitis of neuromyelitis optica from sarcoidosis. | Q53246380 | ||
| Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis | Q82449168 | ||
| Treatment of acute transverse myelitis and its early complications | Q84587159 | ||
| Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis | Q88536681 | ||
| Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders | Q90264112 | ||
| P433 | issue | 3 | |
| P921 | main subject | myelitis | Q551085 |
| P304 | page(s) | 301-309 | |
| P577 | publication date | 2019-03-01 | |
| P1433 | published in | JAMA Neurology | Q276813 |
| P1476 | title | Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody | |
| P478 | volume | 76 |
| Q64070100 | A Longitudinally Extensive Spinal Cord Lesion Restricted to Gray Matter in an Adolescent Male |
| Q104567507 | Acute flaccid myelitis: cause, diagnosis, and management |
| Q92827409 | Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines |
| Q90344977 | Case Series: Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Related Disease Spectrum |
| Q90083002 | Challenges in Differentiating Pediatric Autoimmune CNS Diseases with Similar Clinical and Imaging Phenotypes |
| Q66680190 | Clinical Approach to Pediatric Transverse Myelitis, Neuromyelitis Optica Spectrum Disorder and Acute Flaccid Myelitis |
| Q90608422 | Comparison of Clinical Outcomes of Transverse Myelitis Among Adults With Myelin Oligodendrocyte Glycoprotein Antibody vs Aquaporin-4 Antibody Disease |
| Q89905730 | Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies |
| Q90316278 | Long-term efficacy of mycophenolate mofetil in myelin oligodendrocyte glycoprotein antibody-associated disorders: A prospective study |
| Q89705980 | MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation |
| Q89669325 | The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody |
Search more.